About
Compressing Biology to Develop the Next Generation of Therapies
ZipBio utilizes generative artificial Intelligence to revolutionize the development of new therapeutics, addressing some of the most pressing unmet needs in medicine. By creating de novo genes and proteins, the company's solution distill multiple complex functions into compact, highly effective therapeutic molecules.
Identity
| Name | Zip Bio |
|---|---|
| Slug | zip-bio |
| Type / kind | startup |
| Source _id | doLl2Ff2BgBXX46sUkzq63GwOTiArSoqOXdtpMWg5c1bJ7ATj4J6j5 |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Tel Aviv-Yafo |
| HQ address | Tel Aviv-Yafo, Israel |
Web & social
| Website | https://www.ziptx.bio/ |
|---|---|
| https://www.linkedin.com/company/91320516 | |
| Twitter / X | https://twitter.com/ZipBio_Inc |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Funding
| Total raised | $4.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}